Obesity is a condition characterized by excessive fat accumulation, which leads to metabolic syndrome diseases such as hyperglycemia, hyperlipidemia, hyperuricemia, and hypertension. Efforts to reduce obesity can minimize the risk of the disease. This study aims to determine the antiobesity activity of a combination of Sauropus androgynus L. Merr (SA) and Centella asiatica L.Urban (CA) in a Swiss Webster obese mouse model. A total of 36 mice were randomly grouped into six groups, including the control group (receiving drug carriers), positive (receiving drug carriers), and standard (receiving orlistat 15.6 mg/kg BW). Three groups receiving a combination of SA & CA with a dosage ratio SA: CA includes 25:25 mg/kg BW, 25:50 mg/kg BW, 50:25 mg/kg. All groups (except the normal group) induced obesity with a high-fat and high-fructose (HFHF) diet for 28 days. The drug is given orally for 28 days. Body weight, feed index, feces index, organ index, fat index, serum triglyceride levels (TG), and percent inhibition of lipid peroxidation using malondialdehyde (MDA) absorbance were all measured. The results showed that there were significant differences in parameters of body weight, feed index, feces index, organ index, fat index, serum triglyceride (TG) level, lipid-peroxidation inhibition, and histology of adipocytes between groups of animals receiving a combination extracts compared to the positive control group (p<0.05). The study results concluded that the combination of SA and CA had antiobesity activity.